Analysis of Augros Cosmetic Packaging SA (0MVK)
Based on the provided data for Augros Cosmetic Packaging SA (symbol: 0MVK), we can see the following key points:
1. **Price Movement**:
- The closing price on the most recent date available is 7.9, which is the same as the opening price. This indicates no significant price movement on that day.
- The price has been fluctuating around the 6.5 to 7.9 range in the recent data points.
2. **Technical Indicators**:
- The Relative Strength Index (RSI) values are below 30 in most of the data points, indicating the stock may be oversold.
- The Moving Average Convergence Divergence (MACD) indicator is showing negative values, suggesting a bearish trend.
- The Moving Average (MA) indicator values are above the closing prices, indicating a downward trend.
3. **Moving Averages**:
- The Simple Moving Average (SMA) and Exponential Moving Average (EMA) values are consistently above the closing prices, indicating a bearish trend.
- The Weighted Moving Average (WMA) values are also above the closing prices, supporting the bearish trend.
4. **Overall Analysis**:
- The stock seems to be in a bearish phase based on the technical indicators and moving averages.
- The RSI values suggest that the stock may be oversold, which could potentially lead to a reversal in the trend.
- Investors should closely monitor the price movements and wait for confirmation signals before making any trading decisions.
Please note that this analysis is based on the provided data points and may not capture the complete picture of Augros Cosmetic Packaging SA's stock performance.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as EBITDA, revenue, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and percentages held by insiders and institutions. The company's stock price summary provides information on beta, moving averages, and the range of the stock price over the past year.
Valuation metrics show ratios such as PEG ratio, PE ratios, price to book, price to sales, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits information includes details on payout ratio, dividend dates, split dates, dividend rates, and dividend yields.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent increase in sales over the previous two fiscal years.
- The sales figures show fluctuations, indicating potential market volatility or changes in the company's business operations.
These trends in revenue can provide insights into the company's performance, market conditions, and potential areas for further analysis or improvement.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with expected growth in both quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years was 20.1%
It appears that the company has been experiencing a high growth rate in the past 5 years, but analysts expect the growth rate to moderate in the coming years, with a slightly lower rate for the next year compared to the next 5-year average.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. The company has been utilizing stock-based compensation as part of its operations.
8. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40
4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40
Based on these estimates, we can see a generally positive trend in the expected earnings per share both for the upcoming quarters and the next year compared to the previous year's performance. The number of analysts providing estimates also indicates a reasonable level of confidence in these projections.